Wasatch Advisors’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.5M Sell
308,434
-37,710
-11% -$3.19M 0.13% 117
2026
Q1
$34.4M Buy
346,144
+14,296
+4% +$1.86M 0.23% 93
2025
Q4
$40.4M Buy
331,848
+6,646
+2% +$834K 0.24% 93
2025
Q3
$36.5M Sell
325,202
-10,124
-3% -$1.19M 0.2% 107
2025
Q2
$44.9M Sell
335,326
-117,959
-26% -$13M 0.24% 95
2025
Q1
$30.5M Buy
453,285
+11,931
+3% +$821K 0.17% 107
2024
Q4
$27.5M Buy
441,354
+200,603
+83% +$18.7M 0.14% 120
2024
Q3
$37.8M Sell
240,751
-53,976
-18% -$8.32M 0.19% 107
2024
Q2
$44.4M Sell
294,727
-140,244
-32% -$16.8M 0.24% 95
2024
Q1
$32.2M Buy
+434,971
New +$35.9M 0.17% 113
2019
Q4
Sell
-23,363
Closed -$555K 255
2019
Q3
$555K Sell
23,363
-26,928
-54% -$646K 0.01% 236
2019
Q2
$1.46M Buy
+50,291
New +$1.37M 0.01% 226

Other funds holding TMDX

Wasatch Advisors's TMDX Position: Q2 2026 in Review

Wasatch Advisors reduced its Transmedics (TMDX) stake by 11% in Q2 2026, selling an estimated $3.19M and leaving 308,434 shares worth $20.5M. The position accounts for 0.13% of the portfolio, ranked #117.

Wasatch Advisors first reported a position in TMDX in Q2 2019 and has held it in 12 quarters since. The position peaked at $44.9M in Q2 2025. 34 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Wasatch Advisors held 308,434 shares of Transmedics worth $20.5M as of Q2 2026.
  • Wasatch Advisors sold 37,710 Transmedics shares in Q2 2026, an estimated $3.19M.
  • Transmedics made up 0.13% of Wasatch Advisors's portfolio in Q2 2026, its #117 holding.
  • Wasatch Advisors first reported a position in Transmedics in Q2 2019 and has held it in 12 quarters since.
  • Wasatch Advisors's Transmedics position peaked at $44.9M in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Wasatch Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.